BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Assets

Track Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's total assets ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$12.29M
71.80% YoYΔ $-31.31M vs prior year quarter

Peer average

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Assets History

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 vs. peers: Total Assets Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest total assets for AFJKR is $12M as of March 2026. That compares with $44M in the prior-year period — down 71.8% year over year. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Over the past year, AFJKR's total assets moved from $44M to $12M — a 71.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's operating scale or balance-sheet position.

A total assets figure of $12M for AFJKR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AFJKR's total assets ($12M), review year-over-year change from $44M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.